CLS Holdings USA, Inc.

CLS Holdings USA, Inc.

CLSH
CLS Holdings USA, Inc.US flagOther OTC
0.04
USD
- -
- -
5.94MMarket Cap
CLS Holdings USA, Inc.
CLSH
(Other OTC)

Recent

price

0.04

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
- -
- -
- -
- -
- -
- -
0.33
0.38
0.61
0.71
0.38
0.2
0.14
Revenue per Share
- -
-0.01
-0.95
-0.52
-0.94
-0.98
-1.07
-0.97
-0.5
-0.07
-0.23
-0.05
-0.03
Basic EPS, GAAP
- -
-0.01
-0.5
-0.25
-0.23
-0.15
-0.44
-0.16
-0.09
-0.13
-0.01
0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.01
-0.95
-0.82
-1.73
-1.89
-1.8
-2.43
-2.93
-2.97
-1.79
-1.15
-0.83
Book Value per Share
- -
-0.01
-0.37
-0.28
-0.36
-0.06
-0.09
-0.23
-0.54
-0.59
-0.24
-0.14
-0.09
Tangible Book Value per Share
3
3
2
5
5
10
26
32
32
32
61
99
137
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
8
12
19
23
23
20
19
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
-270.12
-23.65
-5.98
-3.87
-5.63
-5.31
-8.07
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
Depreciation Expense
- -
- -
-2
-3
-5
-10
-28
-31
-16
-2
-14
-4
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
154.77
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
-326.5
-257.25
-82.37
-10.34
-59.65
-22.48
-19.5
Profit Margin (%)
- -
- -
-1
-1
-2
-3
6
6
-1
-21
-12
-11
-13
Working Capital
- -
- -
- -
- -
- -
- -
15
19
22
5
8
7
3
LT Debt
- -
- -
-1
-1
-2
-1
25
-5
-15
-17
-14
-13
-12
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.6
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
May'24
Aug'25
Nov'25
ST Debt
2
2
2
LT Borrowings
5
5
2
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
125
181
165
Market Capitalization
4
5
6

Working Capital

FRC

in mil. unless spec.
May'24
Aug'25
Nov'25
Total Current Assets
3
6
4
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
1
1
1
Inventories
2
2
2
Total Current Liabilities
14
16
17
Payables & Accruals
12
14
14
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-210.4%
9.17%
-6.46%
Free Cash Flow
567.58%
-82.28%
-272.86%
Net Income, GAAP
607.06%
59.81%
-67.48%
Sales/Revenue/Turnover
- -
21.72%
-13.71%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
6
6
5
6
23
2024
5
5
5
5
20
2025
5
4
4
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.04
-0.12
-0.01
- -
-0.23
2024
-0.01
-0.02
-0.04
- -
-0.05
2025
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
CLS Holdings USA, Inc., known as Cannabis Life Sciences, operates as an integrated cannabis enterprise specializing in cannabinoid extraction and product development across the United States. The company employs proprietary methods to extract cannabinoids from cannabis plants, transforming them into various concentrates such as oils, waxes, edibles, and shatters. Its operations encompass selling organic medical cannabis to licensed retailers, providing recreational marijuana products to authorized distributors and retail outlets, and offering diverse extraction products derived from its in-house cultivation. Additionally, CLS Holdings delivers processing and extraction services for licensed medical cannabis cultivators, alongside providing cannabis plant cuttings to licensed growers. The company also extends consulting and toll processing services to various cannabis businesses, including cultivators, dispensaries, and laboratories. Its product portfolio is distributed under the well-recognized Oasis Cannabis and City Trees brands, with concentrates frequently applied in pharmaceutical and other applications. City Trees is noted as a leading vape brand in Nevada, and the company is actively expanding its presence, with City Trees having recently entered the recreational markets in New York and New Mexico through licensing agreements. CLS Holdings is committed to sustainability, evidenced by its partnership with AE Global to introduce plastic-negative exit bags at its Oasis Cannabis dispensary in Nevada. The company was established in 2014 and is headquartered in Las Vegas, Nevada.

Company News

APIChat
  • CSE Bulletin: Delist - CLS Holdings USA, Inc. (CLSH)

  • CLS Holdings USA, Inc. Provides Update on Reverse Stock Split (Share Consolidation) and Announces CSE Delisting

  • CLS Holdings USA, Inc. Partners with AE Global to Tackle the Plastic Crisis

  • CLS Holdings USA, Inc. Announces Exciting New Product Developments for City Trees Brand

  • CLS Holdings USA Inc. Reports Fiscal Year 2024 Third Quarter Performance and Provides Comprehensive Industry Outlook

  • CLS Holdings USA, Inc. Announces Exciting Expansion of City Trees Cannabis Vape Brand into New York's Recreational Market

  • CLS Holdings Partners with SOMA to Launch Innovative Solventless Cannabis Vape

  • CLS Holdings USA Inc. ("CLSH") Announces Repayment of $1,526,250 in Principal and Interest Debenture Obligations along with the Repurchase of 13,274,780 Shares of the Company

  • CLS Holdings USA Inc. ("CLSH") Announces Repayment of $1,526,250 in Principal and Interest Debenture Obligations Along with the Repurchase of 13,274,780 Shares of the Company

  • City Trees Production Facility Achieves Unprecedented Milestone with Record-Breaking Sales Month

  • CLS Holdings USA Inc. (“CLSH”) Announces Repayment of $3,875,094 in Principal Debenture Obligations

  • CLS Holdings USA, Inc. Announces Amendments to Convertible Debentures and Underlying Warrants

  • Oasis Cannabis Dispensaries' 8-Year Anniversary: A Celebration of Success, Growth, and Employee Dedication

  • City Trees Announces New Market Venture in New Mexico Through Licensing Agreement.

  • CLS Reports Fiscal First Quarter 2024 Financial Results

  • CLS Holdings USA, Inc. 2023 CEO Address to Shareholders

  • CLS Holdings Reports Fiscal Year End 2023 Financial Results and Operational Highlights

  • Oasis Cannabis Dispensary Launches Their New and Improved App to Enhance the Customer Experience

  • Oasis Cannabis Utilizing AI-Powered Budtender Offering Personalized Recommendations & ChatGPT Agent

  • CLS Holdings USA, Inc. Discusses Growth Strategy and Significant Debt Reduction with The Stock Day Podcast